Clinical Decision Making Based on Histopathologic Grading and Margin Status of Dysplastic Nevi
Authors:
- Keith L. DuffyKDKeith L. Duffy
- David J. MannDMDavid J. Mann
- Vesna Petronic-RosicVPVesna Petronic-Rosic
- Christopher R. SheaCSChristopher R. Shea
- 1 February 2012
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 148 (2) , 259-260
Abstract
Letter from JAMA Dermatology — Clinical Decision Making Based on Histopathologic Grading and Margin Status of Dysplastic NeviKeywords
This publication has 4 references indexed in Scilit:
- Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic neviJournal of the American Academy of Dermatology, 2010
- The Role of Observation in the Management of Atypical NeviSouthern Medical Journal, 2009
- Terminology and Management of Dysplastic Nevi: Responses From 145 DermatologistsArchives of Dermatology, 2003
- Management of dysplastic nevi: A survey of fellows of the American Academy of DermatologyJournal of the American Academy of Dermatology, 2002